Neuromodulation and Deep Brain Stimulation in Epilepsy and Parkinsons Disease

Deep Brain Stimulation (DBS) and other neuromodulation techniques are transforming the therapeutic landscape for neurological disorders such as epilepsy and Parkinson’s disease. This CME/CE course offers a comprehensive look at the indications, mechanisms, clinical applications, and innovations in neuromodulation, equipping clinicians with the tools to provide advanced, evidence-based care for these challenging conditions.

Participants will begin by exploring the historical development of DBS and its established role in managing movement disorders, particularly Parkinson’s disease. The course details how stimulation of specific brain targets—such as the subthalamic nucleus (STN) and globus pallidus internus (GPi)—can lead to substantial improvements in motor function, tremor control, and quality of life.

For epilepsy, DBS is now an FDA-approved treatment for medically refractory cases. Learners will study the mechanism of action behind thalamic stimulation (e.g., anterior nucleus of the thalamus), understand the clinical selection criteria for DBS candidates, and review outcomes from major clinical trials such as the SANTE trial.

The course also explores emerging neuromodulation technologies, including responsive neurostimulation (RNS), non-invasive brain stimulation (like transcranial magnetic stimulation, or TMS), and closed-loop DBS systems. Each technique is reviewed for its efficacy, safety profile, and current stage of clinical adoption.

Ethical considerations, patient selection, multidisciplinary team involvement, and postoperative management are also discussed. Through real-world case studies, learners will gain insights into how to integrate neuromodulation into comprehensive care plans and how to educate patients on expectations, risks, and long-term outcomes.

By the end of this course, healthcare professionals will understand both the foundational and cutting-edge uses of neuromodulation in epilepsy and Parkinson’s disease, supporting optimal patient-centered care through informed clinical decisions.

Educational Objectives

• Identify clinical indications, brain targets, and expected outcomes of deep brain stimulation (DBS) in Parkinson’s disease and epilepsy.
• Explore new and emerging neuromodulation approaches, including responsive neurostimulation (RNS) and non-invasive modalities, and evaluate their applications and limitations.

Who Should Do This Course?

This course is recommended for:

• Neurologists and Neurosurgeons involved in the care of epilepsy or movement disorders.
• Epileptologists and Movement Disorder Specialists considering surgical interventions.
• Nurse Practitioners and Physician Assistants managing DBS or RNS device follow-up and education.
• Rehabilitation Specialists and Physical Medicine physicians supporting post-operative recovery.
• General Practice and Geriatric providers working with patients with neurodegenerative conditions.

The course is especially relevant for clinicians exploring technology-driven treatment alternatives for patients with drug-resistant epilepsy or advanced Parkinson’s disease.

Did You Know?

• More than 160,000 patients worldwide have received DBS implants for neurological disorders. (World Neurosurgery, 2021)
• The SANTE trial demonstrated a 69% median seizure reduction at 5 years with DBS in epilepsy. (Neurology, 2015)
• Responsive Neurostimulation (RNS) reduces seizures by up to 75% in long-term studies. (Epilepsia, 2020)
• DBS can reduce medication burden in Parkinson’s patients by 30%-60%. (JAMA Neurology, 2018)
• Newer closed-loop DBS systems are being tested for adaptive stimulation based on brain signals. (Nature Biomedical Engineering, 2022)